A modified regimen of pegylated liposomal doxorubicin, bortezomib, and dexamethasone is effective and well tolerated in the treatment of relapsed or refractory multiple myeloma
Gabriel N. Waterman, Ori Yellin, Regina A. Swift, Russell Mapes, Benjamin Eades, Emily Ackerman, James R. BerensonVolume:
90
Language:
english
Pages:
8
DOI:
10.1007/s00277-010-1052-8
Date:
February, 2011
File:
PDF, 206 KB
english, 2011